Javascript must be enabled to continue!
The renin–angiotensin system as a primary cause of polyarteritis nodosa in rats
View through CrossRef
AbstractPolyarteritis nodosa is a necrotizing vasculitis of medium‐sized arteries of unknown origin. Hypertension is present in 30% of patients with polyarteritis nodosa. In those cases, high renin levels are thought to be secondary to renal involvement. The present study was performed to identify causal factors of polyarteritis nodosa. In cyp1a1ren‐2 transgenic rats, vasculitis of medium‐sized arteries resembling classical polyarteritis nodosa can be induced. In this model, oral administration of indole‐3‐carbinol (I3C) activates the liver‐specific cyp1a1 promoter, leading to prorenin expression in a dose‐dependent manner. After the first 6 weeks of chronic induction with 0.125% I3C, the mean arterial pressure reached a plateau of about 170 mmHg. Ten out of 11 I3C‐treated rats, which were chronically instrumented with a telemetric device to measure blood pressure, developed polyarteritis nodosa within 10 weeks of I3C treatment. I3C alone or instrumentation alone did not cause polyarteritis nodosa. The angiotensin‐converting enzyme inhibitor captopril completely prevented the development of polyarteritis nodosa, indicating that local angiotensin II generation is a pathogenetic factor in this model. The renin–angiotensin system can play a primary role in the development of polyarteritis nodosa in rats.
Title: The renin–angiotensin system as a primary cause of polyarteritis nodosa in rats
Description:
AbstractPolyarteritis nodosa is a necrotizing vasculitis of medium‐sized arteries of unknown origin.
Hypertension is present in 30% of patients with polyarteritis nodosa.
In those cases, high renin levels are thought to be secondary to renal involvement.
The present study was performed to identify causal factors of polyarteritis nodosa.
In cyp1a1ren‐2 transgenic rats, vasculitis of medium‐sized arteries resembling classical polyarteritis nodosa can be induced.
In this model, oral administration of indole‐3‐carbinol (I3C) activates the liver‐specific cyp1a1 promoter, leading to prorenin expression in a dose‐dependent manner.
After the first 6 weeks of chronic induction with 0.
125% I3C, the mean arterial pressure reached a plateau of about 170 mmHg.
Ten out of 11 I3C‐treated rats, which were chronically instrumented with a telemetric device to measure blood pressure, developed polyarteritis nodosa within 10 weeks of I3C treatment.
I3C alone or instrumentation alone did not cause polyarteritis nodosa.
The angiotensin‐converting enzyme inhibitor captopril completely prevented the development of polyarteritis nodosa, indicating that local angiotensin II generation is a pathogenetic factor in this model.
The renin–angiotensin system can play a primary role in the development of polyarteritis nodosa in rats.
Related Results
Effect of Acid, Trypsin and Cold Treatment and of Renin— Plasma Interaction on the Activity of Renin Secreted by Rat Kidney
Effect of Acid, Trypsin and Cold Treatment and of Renin— Plasma Interaction on the Activity of Renin Secreted by Rat Kidney
1. Renin release from the isolated perfused rat kidney was markedly stimulated by isoprenaline or anoxia. Renin secreted into the blood-free perfusate was not activated by exposure...
Salmonella infection as a trigger for Polyarteritis Nodosa
Salmonella infection as a trigger for Polyarteritis Nodosa
Polyarteritis nodosa is a systemic necrotizing vasculitis that typically affects medium-sized muscular arteries, with occasional involvement of small muscular arteries. Most cases ...
Case Report: A case of cutaneous polyarteritis nodosa in a child following a streptococcal infection
Case Report: A case of cutaneous polyarteritis nodosa in a child following a streptococcal infection
BackgroundPolyarteritis nodosa is a rare systemic necrotizing vasculitis that is often overlooked and misdiagnosed in clinical practice. Patients may exhibit fever, rash, myalgia, ...
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Abstract 125: Modified Angiotensin II Has Lower Vasoconstrictive Effect Than Angiotensin II
Introduction:
The renin-angiotensin-aldosterone system (RAAS) is involved in the regulation of the blood pressure, water- and electrolyte balance. Pathophysiologically,...
MO093CLARIFICATION OF BIOSYNTHESIS OF ANGIOPROTECTIN
MO093CLARIFICATION OF BIOSYNTHESIS OF ANGIOPROTECTIN
Abstract
Background and Aims
The renin-angiotensin-aldosterone system (RAAS) is involved in the regulation of the blood pressure...
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Development of angiotensin (1‐7) as an agent to accelerate dermal repair
Angiotensin II has been shown to be a potent agent in the acceleration of wound repair. Angiotensin (1‐7), a fragment of angiotensin II that is not hypertensive, was found to be co...
Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct
Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct
Renin is synthesized in the principal cells of the collecting duct (CD), and its production is increased via cAMP in angiotensin (ANG) II-dependent hypertension, despite suppressio...
Pathological Role of Angiotensin II in Severe COVID-19
Pathological Role of Angiotensin II in Severe COVID-19
AbstractThe activated renin–angiotensin system induces a prothrombotic state resulting from the imbalance between coagulation and fibrinolysis. Angiotensin II is the central effect...

